One-Year Follow-up Safety Study in Subjects Previously Implanted With VC-01™

The purpose of this trial is to evaluate the long-term safety in subjects previously implanted with VC-01™ combination product.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type 1 Diabetes Mellitus Autoimmune Diseases Diabetes Mellitus Diabetes Mellitus, Type 1 Endocrine System Diseases Glucose Metabolism Disorders Immune System Diseases Metabolic Diseases Nutritional and Metabolic Diseases

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Previous implantation of VC-01™ combination product with subsequent explantation of all VC-01 units.

Exclusion criteria

There are no exclusion criteria for this trial.

Treatment and study plan

Primary outcomes

Incidence of adverse events reported during the study.

Time frame: 12 months

Sponsors and collaborators

Lead sponsor

ViaCyte

Industry

Registry information

Official study title

A One-Year, Multicenter, Observational, Follow-up Safety Study in Subjects Previously Implanted With VC-01™ Combination Product

Important dates

Study start: 2016
Primary completion: 2024
Study completion: 2024
First posted: Oct 19, 2016
Registry last updated: Apr 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed